Literature DB >> 27141158

Neuropathic pain.

Junad Khan1.   

Abstract

Entities:  

Year:  2016        PMID: 27141158      PMCID: PMC4837768          DOI: 10.4103/0972-4052.179317

Source DB:  PubMed          Journal:  J Indian Prosthodont Soc        ISSN: 0972-4052


× No keyword cloud information.
Neuropathic pain (NP) is defined as “pain arising as a direct consequence of any lesion or disease affecting the somatosensory system.”[12] Although NP may be an idiopathic process reflecting abnormal sensory processing in the peripheral or central nervous system, it more often appears following physical insult or disease affecting the peripheral or central nervous system. It is likely that chronic peripheral neuropathy may lead to neuroplastic changes and affect the central nervous system. These functional and anatomical changes can exacerbate the overall experience of pain. As the changes become more chronic, co-morbid conditions such as sleep disorders, anxiety and depression can accompany the chronic pain, and further complicate treatment. The prevalence of NP conditions is difficult to establish. There are many confounding factors that may lead to under-reporting of NP. In primary medical care settings, the prevalence has been reported to be between 2 and 11%.[34] Studies have focused on specific NP conditions, secondary to other pathological conditions. It has been shown that the about 26% of patients with type 2 diabetes can experience neuropathy. Cancer patients indicate a prevalence of 19–39. About 1% and 37% of chronic low back pain patients may have a neuropathic component related to it.[567] Even with high prevalence in chronic conditions, the overall numbers of NP conditions tends to be small. One of the reasons is the lack of identification, diagnosis, and treatment. There is no standard approach between health care providers for NP. NP can be localized to the craniofacial region such as in trigeminal and glossopharyngeal neuralgia, painful traumatic trigeminal neuropathy (PTTN), burning mouth syndrome, or may affect other areas of the body such as in case of diabetic neuropathy. In the orofacial region, NP mainly affects the trigeminal nerve and can be referred to as Neuropathic Orofacial Pain (NOP). Peripheral NP can be a result of nerve damage. Different types of nerve damage such as crush, transection, partial transection, and inflammatory insult can induce various clinical pain presentations and further complicate the process of diagnosis and management. In the orofacial region, development of pain following nerve damage (i.e., PTTN) is around 3–5%, which is low when compared to other parts of the body, where an incidence of painful traumatic neuropathy is 5–17%.[891011] PTTN secondary to dental procedures can be a major complication. Third molar extractions have been reported to cause altered sensations in 0.3–1% of cases.[121314] Persistent pain after successful endodontics has been found to occur in 3–13% of the patients.[151617] The incidence of neurosensory disturbance post implant can range anywhere from 0.6 to 36%.[18192021] Causes of central pain may include trauma, cerebrovascular injuries, tumors, multiple sclerosis, and Parkinson's disease. NP can also be classified based on frequency into continuous or episodic. Episodic neuropathies are usually characterized by short, sudden, sharp, or electrical like paroxysmal pain. The pain is usually severe and sporadic in nature. Continuous NP is usually characterized by continuous dull pain of mild to moderate intensity with occasional paroxysms of pain. There is presently no definitive cure to this condition, and the available treatment requires long-term prescription medications with significant side effects. In some cases, surgical procedures and adjunctive therapy are also recommended. Evaluation of sensory alterations can be performed using quantitative sensory testing which is a noninvasive assessment of normal and abnormal responses of the nervous system to various stimuli. Mapping and sketches of the affected area can help treatment decisions and management. The medications used for NP can include antidepressants, anticonvulsants, antiarrhythmics, opioids and nonopioid analgesics, and topical medications.[22] Adjunctive treatment can include but is not limited to a variety of options which include physical therapy, acupuncture, hypnosis, counseling, biofeedback, massage, relaxation, pressure, herbs, yoga, exercise, and electrotherapy. The prevailing “trial and error” approach to NP treatment includes a titration regimen of 3–8 weeks which is very often repeated several times before an effective medication for the individual patient is identified. As health care providers it is important to recognize NOP conditions to avoid unnecessary treatment and suffering.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  22 in total

Review 1.  Chronic pain after surgery.

Authors:  W A Macrae
Journal:  Br J Anaesth       Date:  2001-07       Impact factor: 9.166

Review 2.  A multicenter report on osseointegrated oral implants.

Authors:  T Albrektsson
Journal:  J Prosthet Dent       Date:  1988-07       Impact factor: 3.426

3.  Chronic pain prevalence and analgesic prescribing in a general medical population.

Authors:  J David Clark
Journal:  J Pain Symptom Manage       Date:  2002-02       Impact factor: 3.612

4.  Chronic facial pain associated with endodontic therapy.

Authors:  R L Campbell; K W Parks; R N Dodds
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1990-03

5.  Screening of neuropathic pain components in patients with chronic back pain associated with nerve root compression: a prospective observational pilot study (MIPORT).

Authors:  Rainer Freynhagen; Ralf Baron; Thomas Tölle; Edgar Stemmler; Ulrich Gockel; Markus Stevens; Christoph Maier
Journal:  Curr Med Res Opin       Date:  2006-03       Impact factor: 2.580

Review 6.  NeuPSIG guidelines on neuropathic pain assessment.

Authors:  Maija Haanpää; Nadine Attal; Miroslav Backonja; Ralf Baron; Michael Bennett; Didier Bouhassira; Giorgio Cruccu; Per Hansson; Jennifer A Haythornthwaite; Gian Domenico Iannetti; Troels S Jensen; Timo Kauppila; Turo J Nurmikko; Andew S C Rice; Michael Rowbotham; Jordi Serra; Claudia Sommer; Blair H Smith; Rolf-Detlef Treede
Journal:  Pain       Date:  2010-09-19       Impact factor: 6.961

Review 7.  Lingual nerve damage during lower third molar removal: a comparison of two surgical methods.

Authors:  P P Robinson; K G Smith
Journal:  Br Dent J       Date:  1996-06-22       Impact factor: 1.626

8.  Neurosensory changes in the infraorbital nerve following zygomatic fractures.

Authors:  Rafael Benoliel; Ravit Birenboim; Eran Regev; Eli Eliav
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2005-06

9.  Endodontic treatment outcomes: do patients perceive problems?

Authors:  W K Lobb; K L Zakariasen; P J McGrath
Journal:  J Am Dent Assoc       Date:  1996-05       Impact factor: 3.634

10.  A 21 year retrospective study of reports of paresthesia following local anesthetic administration.

Authors:  D A Haas; D Lennon
Journal:  J Can Dent Assoc       Date:  1995-04       Impact factor: 1.316

View more
  3 in total

1.  Altered somatosensory processing in secondary trigeminal neuralgia: A case report.

Authors:  Noboru Noma; Kana Ozasa; Andrew Young
Journal:  J Indian Prosthodont Soc       Date:  2021 Jul-Sep

Review 2.  Trigeminal Traumatic Neuroma: a Comprehensive Review of the Literature Based On a Rare Case.

Authors:  Davis C Thomas; Saranya Devatha Mallareddy; Jeffrey P Okeson; Josna Thankachan; Priyanka Kodaganallur Pitchumani; Reshmy Chellam Pichammal
Journal:  Curr Pain Headache Rep       Date:  2022-02-04

3.  Bilateral intraoral traumatic neuroma: Case report of a diagnostic challenge.

Authors:  Davis C Thomas; Rangarajan Vedantham; Nishanthini Annamalai; Priyanka Kodaganallur Pitchumani
Journal:  J Indian Prosthodont Soc       Date:  2021 Oct-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.